A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY.

Department of Health and Human Services

Award: Department of Health and Human ServicesNAICS n/aSAM# 75N93022C00061

Posted 2026-07-19 · Response deadline 2028-04-25 · Set-aside: None

Recipient: REVAGENIX INC | $28167401.0

View official SAM.gov notice →

← All opportunities